Tags

Type your tag names separated by a space and hit enter

Sensitizations to allergens of TRUE test in 864 consecutive eczema patients in Israel.
Contact Dermatitis. 2006 Dec; 55(6):370-1.CD

Abstract

The TRUE test is a widespread diagnostic tool for initial patch testing of patients with contact dermatitis (CD). From 2002 to 2005, 864 patients with eczema were patch-tested using TRUE test in one Israeli allergology clinic. 547 (63.3%) patients were female and 317 (36.7%) were male. 346 (40%) patients had > or =1 positive patch test reactions. The most common allergens were nickel sulfate for 114 (13.2%) patients, potassium dichromate 111 (12.8%), fragrance mix 59 (6.8%), cobalt chloride 12 (1.4%), ethylenediamine dihydrochloride 11 (1.3%), epoxy resin 11 (1.3%), balsam of Peru 9 (1.0%), carba mix 7 (0.8%), thiomersal 6 (0.7%), wool alcohol 5 (0.6%), black rubber (PPD) mix 5 (0.6%), neomycin 4 (0.5%); Kathon CG, Colophony and Quaternium 15 - each 2 (0.2%), other allergens - each 1 (0.1%). In male patients, carba mix, black rubber (PPD) mix and epoxy resin sensitivity was more frequent, whereas nickel sulfate, fragrance mix, ethylenediamine dihydrochloride and cobalt chloride sensitivity was significantly more frequent in female patients. Our results are in general agreement with previously published reports, excluding the low sensitivity rates to cobalt, which maybe is missed by TRUE test.

Authors+Show Affiliations

Medicine B Department, Barzilai Medical Center, Ben Gurion University of Negev, Ashkelon, Israel. elimgen2@netvision.net.ilsNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

17101019

Citation

Magen, Eli, et al. "Sensitizations to Allergens of TRUE Test in 864 Consecutive Eczema Patients in Israel." Contact Dermatitis, vol. 55, no. 6, 2006, pp. 370-1.
Magen E, Mishal J, Schlesinger M. Sensitizations to allergens of TRUE test in 864 consecutive eczema patients in Israel. Contact Dermatitis. 2006;55(6):370-1.
Magen, E., Mishal, J., & Schlesinger, M. (2006). Sensitizations to allergens of TRUE test in 864 consecutive eczema patients in Israel. Contact Dermatitis, 55(6), 370-1.
Magen E, Mishal J, Schlesinger M. Sensitizations to Allergens of TRUE Test in 864 Consecutive Eczema Patients in Israel. Contact Dermatitis. 2006;55(6):370-1. PubMed PMID: 17101019.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sensitizations to allergens of TRUE test in 864 consecutive eczema patients in Israel. AU - Magen,Eli, AU - Mishal,Joseph, AU - Schlesinger,Menachem, PY - 2006/11/15/pubmed PY - 2007/2/16/medline PY - 2006/11/15/entrez SP - 370 EP - 1 JF - Contact dermatitis JO - Contact Dermatitis VL - 55 IS - 6 N2 - The TRUE test is a widespread diagnostic tool for initial patch testing of patients with contact dermatitis (CD). From 2002 to 2005, 864 patients with eczema were patch-tested using TRUE test in one Israeli allergology clinic. 547 (63.3%) patients were female and 317 (36.7%) were male. 346 (40%) patients had > or =1 positive patch test reactions. The most common allergens were nickel sulfate for 114 (13.2%) patients, potassium dichromate 111 (12.8%), fragrance mix 59 (6.8%), cobalt chloride 12 (1.4%), ethylenediamine dihydrochloride 11 (1.3%), epoxy resin 11 (1.3%), balsam of Peru 9 (1.0%), carba mix 7 (0.8%), thiomersal 6 (0.7%), wool alcohol 5 (0.6%), black rubber (PPD) mix 5 (0.6%), neomycin 4 (0.5%); Kathon CG, Colophony and Quaternium 15 - each 2 (0.2%), other allergens - each 1 (0.1%). In male patients, carba mix, black rubber (PPD) mix and epoxy resin sensitivity was more frequent, whereas nickel sulfate, fragrance mix, ethylenediamine dihydrochloride and cobalt chloride sensitivity was significantly more frequent in female patients. Our results are in general agreement with previously published reports, excluding the low sensitivity rates to cobalt, which maybe is missed by TRUE test. SN - 0105-1873 UR - https://www.unboundmedicine.com/medline/citation/17101019/Sensitizations_to_allergens_of_TRUE_test_in_864_consecutive_eczema_patients_in_Israel_ L2 - https://doi.org/10.1111/j.1600-0536.2006.00878.x DB - PRIME DP - Unbound Medicine ER -